Trial intelligence / Profile preview

Ganfort vs Duotrav in Glaucoma and Ocular Hypertension

NCT01168414Phase 3Completed

Sponsor
Ministry of Health Malaysia
Start
Aug 2010
Primary completion
Jan 2011
Modality
Prodrugs/Conditional Activator Small Molecules
Countries
1
01

Overview

A Phase 3 trial of bimatoprost + timolol, travoprost in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Ministry of Health Malaysia. Started Aug 2010; status: completed.

02

Drugs

bimatoprost + timololtravoprost
03

Conditions

primary open-angle glaucoma (POAG)ocular hypertension

Beyond the preview

Go deeper on NCT01168414.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01168414.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call